Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vaxcyte Q3 EPS $(0.93) Down From $(0.51) YoY

Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(0.93) per share. This is a 82.35 percent decrease over losses of $(0.51) per share from the same period last year.
byBenzinga Newsdesk
November 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(0.93) per share. This is a 82.35 percent decrease over losses of $(0.51) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Moderna Shares Are Falling

By Henry Khederian
February 24, 11:40 AM
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 4.59% to $140.80 Friday morning after SVB Leerink downgraded the stock from Market Perform to Underperform and lowered its price target from $111 to $93.

MRNA